Richard Tettey Addo

Dr. Richard Tettey Addo is a Professor of Pharmaceutical Sciences at Union University, where he teaches pharmaceutical calculations, Pharmaceutics, and sterile and non-sterile compounding to first and second year pharmacy students. He has previously served as an Assistant Professor of Pharmaceutical Sciences at Shenandoah University and as an Adjunct Professor of Pharmacogenomics at George Washington University School of Medicine.

Dr. Addo's educational background includes:

• Ph.D. in Pharmaceutical Sciences from Mercer University College of Pharmacy and Health Sciences (2008)
• Bachelor of Science degree in Pharmacy (B. Pharm) from the University of Science and Technology, Ghana (2002)

Dr. Addo's research focuses on innovative drug delivery systems, particularly in the areas of nanoparticle and microparticle formulation for protein pharmaceuticals. His work encompasses the stability of compounded formulations, dosage forms, and the development of delivery platforms for vaccines and cancer therapeutics. A significant aspect of his research involves creating controlled release biodegradable and targetable particle drug delivery systems prepared by one-step spray drying. His long-term research goal is to develop vaccine delivery strategies using micro- and nanoparticles that can stimulate the body's immune recognition and facilitate long-lasting immunity.

Dr. Addo's scholarly output demonstrates a consistent focus on drug delivery systems, particularly for ocular applications, cancer therapeutics, and vaccine development. His work spans from fundamental formulation studies to preclinical evaluations, showing progression from basic research to more applied therapeutic development. The publications reveal expertise in albumin-based delivery systems, nanoparticle technology, and analytical method development for pharmaceutical products.

Dr. Addo has received recognition for his scholarly work, including:

• Outstanding Poster and Presentation Award Winner at Graduate Research Association of Students of Pharmacy (GRASP), Florida A. and M. University, Tallahassee, Florida (2008)

Dr. Addo has secured multiple research grants supporting his work in drug delivery and pharmaceutical formulation. These include funding from Union University's Pew Research Program for developing nano-sized particles containing anti-oxidants for age-related macular degeneration treatment, and grants from Main Street Pharmacy and the International Academy of Compounding Pharmacists for stability testing of compounded drugs. His grant portfolio reflects both academic and industry interest in his research on pharmaceutical formulation and drug delivery systems.

While specific laboratory facilities aren't detailed in the available information, Dr. Addo's research program appears to focus on formulation development and characterization of drug delivery systems, particularly involving albumin-based micro- and nanoparticles. His work likely involves collaboration with other researchers in pharmaceutical sciences and potentially with clinicians for translational applications of his delivery systems.